Dividend policy issues in the European pharmaceutical industry: new empirical evidence

This paper examines dividend policy issues in the European pharmaceutical industry. This sector is of particular interest because of the high research and development expenditures and the associated risks characterizing the business models of many firms in this industry. In fact, from the perspectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Basse, Tobias, Schwarzbach, Christoph, Graf von der Schulenburg, J.-Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198850/
https://www.ncbi.nlm.nih.gov/pubmed/36018442
http://dx.doi.org/10.1007/s10198-022-01510-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198850/
https://www.ncbi.nlm.nih.gov/pubmed/36018442
http://dx.doi.org/10.1007/s10198-022-01510-5

Ejemplares similares